Associations between breast cancer and exposure to environmental carcinogens are often weak or inconsistent in the epidemiologic literature, even when strong experimental data exists. The strongest support for environmental carcinogenesis comes from mouse models showing that exposures such as ionizing radiation (IR) and polycyclic aromatic hydrocarbons (PAHs) increase mammary tumor formation. These same experimental models have shown that parity has a p53-mediated, protective effect against carcinogenesis. This application proposes a comparative toxicology approach for dissecting the biological pathways that lead to environmental carcinogenesis of the breast, with emphasis on interactions between environmental carcinogens, the p53 pathway, and parity. Three classes of environmental exposure, each with a strong epidemiologic and toxicological literature, have been selected for study: IR, PAHs, and organochlorines (OCs). The first two classes (IR and PAHs) both cause DNA damage and induce p53-dependent DNA damage responses, but the DNA damage mechanisms are different. In contrast, OCs do not act by directly damaging DNA, and thus, provide a negative control for p53-dependent signaling. OCs also provide a comparison for the PAHs as both PAHs and OCs can activate the aryl hydrocarbon receptor (AhR) and perturb endocrine action in the breast.
In Aim 1, we will assess the p53 dependent effects of each toxicant using isogenic human breast cell lines (with and without expression of p53RNAi to knockdown p53 expression) and nulliparous Trp53+/+ and Trp53-/- mice.
In Aim 2, we will examine gene expression profiles associated with parity in humans (using reduction mammoplasty samples) and mice, with specific attention to identifying p53-regulated gene expression.
In Aim 3, the interaction between parity and environmental carcinogenesis will be assessed by comparing transcriptional responses to toxicants in parous and age-matched nulliparous mice. Differential responses to toxicants will be verified in explant cultures of human breast tissue from nulliparous and parous women (excess tissue from reduction mammoplasty). Thus, each aim will integrate human and mouse responses to define responses to toxicants and parity. The data from all three aims will be integrated to allow a complete, multifactorial evaluation of how environmental exposures to these toxicants, p53 signaling, and parity status interact to affect breast signaling, and ultimately carcinogenesis. These studies will define the mechanisms of environmentally-induced breast cancer, anchored on genotype-phenotype correlations that define susceptibility, and will identify new candidate biomarkers of susceptibility that can be used in future animal and human studies.

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZES1-LWJ-E (CG))
Program Officer
Balshaw, David M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Massachusetts Amherst
Veterinary Sciences
Schools of Earth Sciences/Natur
United States
Zip Code
Sturgeon, Susan R; Arcaro, Kathleen F; Johnson, Melissa A et al. (2014) DNA methylation in paired breast epithelial and white blood cells from women undergoing reduction mammoplasty. Anticancer Res 34:2985-90
Jerry, D Joseph; Makari-Judson, Grace; Crisi, Giovanna M et al. (2013) Pregnancy offers new insights into mechanisms of breast cancer risk and resistance. Breast Cancer Res 15:312
Pirone, Jason R; D'Arcy, Monica; Stewart, Delisha A et al. (2012) Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol Biomarkers Prev 21:1735-44
Dunphy, Karen A; Schneyer, Alan L; Hagen, Mary J et al. (2011) The role of activin in mammary gland development and oncogenesis. J Mammary Gland Biol Neoplasia 16:117-26
Blackburn, Anneke C; Jerry, D Joseph (2011) Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models. J Mammary Gland Biol Neoplasia 16:57-64
Camp, J Terese; Elloumi, Fathi; Roman-Perez, Erick et al. (2011) Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers. Mol Cancer Res 9:3-13
Compton, Shannon; Kim, Chul; Griner, Nicholas B et al. (2011) Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J Biol Chem 286:20297-312
Tao, Luwei; Roberts, Amy L; Dunphy, Karen A et al. (2011) Repression of mammary stem/progenitor cells by p53 is mediated by Notch and separable from apoptotic activity. Stem Cells 29:119-27
Jerry, D Joseph; Dunphy, Karen A; Hagen, Mary J (2010) Estrogens, regulation of p53 and breast cancer risk: a balancing act. Cell Mol Life Sci 67:1017-23
Yan, Haoheng; Blackburn, Anneke C; McLary, S Christine et al. (2010) Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice. Am J Pathol 176:1421-32

Showing the most recent 10 out of 14 publications